New phase 3 trial data reveal fremanezumab's effectiveness and safety for preventing migraines in children, offering a vital treatment option.
Andrew D. Hershey, MD, PhD
Advertisement
Andrew D. Hershey, MD, PhD, is endowed chair and director of neurology at Cincinnati Children’s Hospital Medical Center.
Articles by Andrew D. Hershey, MD, PhD
Advertisement
Latest Updated Articles
Andrew Hershey, MD, discusses latest phase 3 results of fremanezumab-vfrm for pediatric episodic migrainePublished: January 15th 2026 | Updated:
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA issues complete response letter for sublingual epinephrine film Anaphylm
2
Melatonin use in children calls for caution, experts say
3
Early screening for type 1 diabetes found effective in children
4
Top 5 pediatric health headlines you missed in January 2026
5